A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine

A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine

Objective: This study aimed to investigate the breakthrough infection rate and safety profile of the AstraZeneca vaccine. Methods: The breakthrough COVID-19 infection rate was defined as a positive polymerase chain reaction test 14 days after the vaccine dose. Safety was assessed as local reactions...

Full description

Saved in:
Bibliographic Details
Main Authors: Nawfal R. Hussein (Author), Bizav Naji Rasheed (Author), Ibrahim A. Naqid (Author), Arshed Mustafa Dirbaz (Author), Zana Sidiq M. Saleem (Author), Nashwan Ibrahim (Author), Dildar H. Musa (Author), Sulav Muslih Mohammed (Author)
Format: Book
Published: Elsevier, 2022-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items